A Study of Nimotuzumab in Combination With Radiation Therapy in Patients With Brain Metastases

NCT00872482 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

21

Enrollment

INDUSTRY

Sponsor class

Stopped Study closed due to low enrollment

Conditions

Metastatic Non-Small Cell Lung Cancer

Interventions

DRUG: nimotuzumab

Sponsor

YM BioSciences

Collaborators

[object Object]